ebm.bmj

Table 1

Low-dose donepezil vs placebo 1.18 (0.62 to 2.32) High-dose donepezil vs placebo 2.62 (1.72 to 4.04) High-dose donepezil vs low-dose donepezil 2.22 (1.17 to 4.20) Low-dose galantamine vs placebo 4.08 ...
ebm.bmj

BMJ Evidence Based Medicine – Deputy Editor Vacancy

Role Advertisement: Deputy Editor Application deadline: 13th November 2026 Start date: Dependant on availability BMJ is seeking an enthusiastic and collaborative Deputy Editor to join the editorial ...
ebm.bmj

Table 3

Missing—impute, NIHSS score—continuous, OTT—continuous 794 1.25 (0.91 to 1.73) 0.173 Missing—impute, NIHSS score—continuous, OTT—categorical 794 1.33 (0.96 to 1.85) 0.086 Missing—impute, NIHSS ...
ebm.bmj

Table 1

Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263(10):1405–8. https://pubmed.ncbi.nlm.nih.gov/2304220/ Jüni P, Altman DG, Egger M ...
BMJ Evidence-Based Medicine

Building capacity in evidence-based healthcare: a mixed-methods evaluation of training activities in South Africa

Objectives Cochrane South Africa (CSA) is a Cochrane geographic group established in 1997, aiming to advance the skills and ...
ebm.bmj

The Impact of Power Driven Overdiagnosis: the Role of Regulators and Health Authorities

135 Trends and variation in the sales of over-the-counter analgesics: a protocol for a retrospective database study and policy review ...
ebm.bmj

Table 2

*RRR, NNT, and CI calculated from data in article or provided by author (Laine). †Simon = Simon LA, Weaver AS, Graham DY,et al.JAMA 1999;282:1921–8. (3 doses of celecoxib combined, 12 wk trial).
ebm.bmj

Table 1

Total number (per cent) of specialties with a requirement Hospital-based residencies (N=11) Medical specialties (N=8) Surgical specialties (N=10) EBM 1: validity of research evidence Knowledge and ...
ebm.bmj

Table 1

*Endometrial carcinoma, glioblastoma, liposarcoma or leiomyosarcoma, malignant mesothelioma, neuroendocrine tumours, pleural mesothelioma, prostate cancer, small cell lung cancer, squamous cell ...
ebm.bmj

Table 1

CI = confidence interval; HCC = hepatocellular carcinoma; NNS = number needed to screen; OR = odds ratio. HCC mortality 0.44% 0.54% 0.81 (0.54 to 1.22) 937/5 y HCC detected 0.92% 0.54% 1.69 (1.20 to 2 ...